AU9128998A - Composition and method for the treatment of benign prostatic hyperplasia and prostatitis - Google Patents
Composition and method for the treatment of benign prostatic hyperplasia and prostatitisInfo
- Publication number
- AU9128998A AU9128998A AU91289/98A AU9128998A AU9128998A AU 9128998 A AU9128998 A AU 9128998A AU 91289/98 A AU91289/98 A AU 91289/98A AU 9128998 A AU9128998 A AU 9128998A AU 9128998 A AU9128998 A AU 9128998A
- Authority
- AU
- Australia
- Prior art keywords
- prostatitis
- treatment
- composition
- benign prostatic
- prostatic hyperplasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92366997A | 1997-09-04 | 1997-09-04 | |
US08923669 | 1997-09-04 | ||
PCT/US1998/018199 WO1999011279A1 (en) | 1997-09-04 | 1998-09-02 | Composition and method for the treatment of benign prostatic hyperplasia and prostatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU9128998A true AU9128998A (en) | 1999-03-22 |
Family
ID=25449071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU91289/98A Abandoned AU9128998A (en) | 1997-09-04 | 1998-09-02 | Composition and method for the treatment of benign prostatic hyperplasia and prostatitis |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU9128998A (en) |
WO (1) | WO1999011279A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001285232A1 (en) * | 2000-08-24 | 2002-03-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Alpha-difluoromethylornithine (dfmo) use in the human prostate |
FR2881649B1 (en) * | 2005-02-10 | 2007-04-06 | Du Sert Patrice Percie | PROCESS FOR EXTRACTING FRESH POLLEN, LIPID EXTRACT OBTAINED AND APPLICATIONS THEREOF |
US8221803B1 (en) | 2007-06-25 | 2012-07-17 | OncoNatural Solutions, Inc. | Composition for prostate health |
CN104055902B (en) * | 2014-06-28 | 2016-08-17 | 张志红 | One treats prostatitic Chinese medicine composition |
CN114158266A (en) | 2019-07-15 | 2022-03-08 | 生物实验萨纽斯药物有限公司 | Stereoisomers of the compound 3- (benzo [ d ] [1,3] dioxol-5-yl) -7- (1-hydroxypropan-2-yl) -1- (1H-indol-3-yl) -6, 7-dihydro-3H-oxazolo [3,4-a ] pyrazine-5, 8-dione and their use as anti-tumour agents and phosphodiesterase inhibitors |
CN114377107B (en) * | 2022-01-14 | 2023-09-05 | 完美(广东)日用品有限公司 | Application of sea buckthorn seed meal protein peptide in preparation of medicine for preventing and treating prostatic hyperplasia |
-
1998
- 1998-09-02 WO PCT/US1998/018199 patent/WO1999011279A1/en active Application Filing
- 1998-09-02 AU AU91289/98A patent/AU9128998A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999011279A1 (en) | 1999-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6393896A (en) | Method for treating benign prostatic hyperplasia with thermal therapy | |
EP1014995A4 (en) | Compositions and methods for preventing restenosis following revascularization procedures | |
AU1316000A (en) | Compositions and methods for treating benign prostatic hyperplasia using tocotrienols | |
AU2212299A (en) | Compositions and methods for the treatment of tumor | |
AU6578998A (en) | Method of treatment of migraine | |
AU9214398A (en) | Compositions and methods for treating water | |
IL189132A0 (en) | Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer | |
AU5173296A (en) | Prostatic tissue expander | |
NO993396L (en) | Quinoline and quinoline compounds useful in therapy, especially in the treatment of benign prostatic hyperplasia | |
AU3011299A (en) | Combination therapy for the treatment of benign prostatic hyperplasia | |
AU2235395A (en) | Biological markers of benign prostate hyperplasia | |
AU9016898A (en) | Methods and compositions for treatment of restenosis | |
IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
AU1657097A (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia | |
EP0855910A4 (en) | Conjugates useful in the treatment of benign prostatic hyperplasia | |
AU1714697A (en) | Method and composition for the treatment of osteoarthritis | |
ZA983968B (en) | Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia. | |
HU9501286D0 (en) | Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis | |
AU9128998A (en) | Composition and method for the treatment of benign prostatic hyperplasia and prostatitis | |
ZA982819B (en) | Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators. | |
HK1030776A1 (en) | Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia | |
EP0633781A4 (en) | Compositions and methods for treating benign prostatic hypertrophy. | |
AU5457694A (en) | Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis | |
AU6172896A (en) | Melatonin agonists for treating benign prostatic hyperplasia | |
AUPO410796A0 (en) | Method of treating benign prostatic hyperplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |